Table 3.
Early mortality and early recurrence based on RAMa, ALBIb and MELDc score classifications
| Early Mortality vs. Lived | P-value | Early recurrence vs. Non-recurrence | P-value | ||
|---|---|---|---|---|---|
| RAM scorea (mean ± SE) | 5.52 ± 0.17 vs. 3.85 ± 0.05 | <0.001 | 4.34 ± 0.06 vs.3.35 ± 0.06 | <0.001 | |
| ALBI scoreb (mean ± SE) | −2.47 ± 0.04 vs. -2.81 ± 0.01 | <0.001 | −2.71 ± 0.01 vs. -2.86 ± 0.01 | <0.001 | |
| MELD scorec (mean ± SE) | 9.32 ± 0.33 vs. 8.27 ± 0.07 | 0.002 | 8.54 ± 0.09 vs. 8.23 ± 0.10 | 0.113 | |
| Number (% of total) | Early mortality (6-month) (%) | P-value | Early recurrence (2-year) (%) | P-value | |
| RAM scorea (n = 1935) | <0.001 | <0.001 | |||
| RAM class I | 1702 (88) | 101 (5.9) | 887 (52.6%) | ||
| RAM class II/III | 233 (12) | 48 (20.6) | 148 (68.2%) | ||
| ALBI scoreb (n = 1892) | <0.001 | <0.001 | |||
| ALBI grade 1 | 1341 (70.9) | 67 (5.0) | 666 (49.7%) | ||
| ALBI grade 2 | 541 (28.6) | 75 (13.9) | 339 (62.7%) | ||
| ALBI grade 3 | 10 (0.5) | 2 (20.0) | 7 (70.0%) | ||
| MELD scorec (n = 1898) | 0.002 | 0.106 | |||
| MELD grade 1 | 1513 (79.7) | 97 (6.4) | 799 (53.5%) | ||
| MELD grade 2 | 319 (16.8) | 37 (11.6) | 183 (58.7%) | ||
| MELD grade 3 | 66 (3.5) | 8 (12.1) | 28 (45.9%) |
aRisk Assessment for early Mortality score
balbumin–bilirubin score
cModel for End-Stage Liver Disease score